Amarin Corp Plc (AMRN)

[rosemountbomber]

As some posters have already noted in response to your post, there are very few leaked study results in blinded clinicals. Once the data is collected and compiled there is always a minuscule chance that someone finds a way to know the results (usually not us common shareholders).

On the other point you made, no one has really commented. That being price appreciation related to speculation of success. Obviously the largest part of the market does not believe Reduce-It will bear fruit or the readout is still too far in the future for people to stake out positions that would raise the pps.

But we here on the board have been regularly inundated with study after study that would lead us to believe that Reduce It will be successful, so if the inferences about these are correct you would think this should ultimately lead to some price appreciation speculation. Of course so many of these posted studies show how EPA works affecting various parameters, but will it change outcomes in humans?